Top Markets
#1 EXOD EXOD +56.80%
#2 CoW Protocol CoW Protocol +52.24%
#3 Glidr Glidr +36.41%
#4 Walrus Walrus +29.81%
#5 Cysic Cysic +20.00%
#6 The Black Bull The Black Bull +18.44%
#7 Humanity Humanity +15.87%
#8 Fabric Protocol Fabric Protocol +14.98%
#9 Nockchain Nockchain +14.31%
#10 Tutorial Tutorial +13.13%
Coin of the day
EXOD EXOD
Settings
Language
ENGLISH
Currency
USD
Theme
Ayurcann Holdings Corp. Ayurcann Holdings Corp.

Ayurcann Holdings Corp.

AYUR
Rank in Stocks #37809
Ayurcann Holdings Corp. provides comprehensive post-harvest outsourcing... Ayurcann Holdings Corp. provides comprehensive post-harvest outsourcing solutions for licensed cannabis producers throughout Canada. Its end-to-end services encompass various stages, including raw material extraction and refinement, bulk distillate oil sales, product formulation, and white-label manufacturing. The company further supports clients with fulfillment, distribution, custom packaging development, and inventory control. In addition to these business-to-business services, Ayurcann produces and markets its own line of medicinal cannabis products, such as tinctures, vapes, and topicals. It also manages the Ayurcann marketplace, an e-commerce platform dedicated to medical cannabis consumers. The company was founded in 2018 and is based in Pickering, Canada.
Share Price
$0.00733937
Last synced: 2026-04-02
Market Cap
$1.43M
Change (1 day)
0.00%
Change (1 year)
-59.43%
Country
CA
Trade Ayurcann Holdings Corp. (AYUR)

Category

Healthcare
P/E ratio for Ayurcann Holdings Corp. (AYUR)
P/E ratio as of 2026 TTM: 0
According to Ayurcann Holdings Corp. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Ayurcann Holdings Corp. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 38.29 -
IN
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.